about
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery te...
Read More
1.30
0.00
(0.00%)
3,033.2
XNAS Volume
XNAS 08 May, 2026 9:42 AM (EDT)
Board Meeting
The next board meeting for Pulmatrix Inc is on 15 May 2026 for the purpose of Pulmatrix Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Pulmatrix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..